RhumbLine Advisers’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
+69,796
| New | +$103K | ﹤0.01% | 3514 |
|
|
2024
Q3 | – | Sell |
-17,666
| Closed | -$20.7K | – | 4302 |
|
|
2024
Q2 | $20.7K | Sell |
17,666
-58,789
| -77% | -$68.8K | ﹤0.01% | 3868 |
|
|
2024
Q1 | $96.3K | Buy |
76,455
+2,769
| +4% | +$3.49K | ﹤0.01% | 3458 |
|
|
2023
Q4 | $131K | Sell |
73,686
-21,717
| -23% | -$38.7K | ﹤0.01% | 3359 |
|
|
2023
Q3 | $158K | Buy |
95,403
+6,830
| +8% | +$11.3K | ﹤0.01% | 3277 |
|
|
2023
Q2 | $177K | Buy |
+88,573
| New | +$177K | ﹤0.01% | 3300 |
|